ACQUISITION OF MEDICINES FOR MILITARY PERSONNEL OF THE LAND COMPONENT OF THE CE VRAEM AF-2026

This public tender, initiated by the Peruvian Army (EJERCITO PERUANO), concerns the acquisition of medicines intended for the military personnel of the Land Component of the CE VRAEM for the fiscal year 2026. The procurement process, identified as LP-SM-4-2025-EP/UO 0790-1, will be conducted through a Public Bidding (Licitación Pública) method. The contracting entity is based in Lima, Peru. The objective is to ensure the adequate supply of pharmaceutical products necessary for the health and well-being of the land forces operating within the VRAEM (Valley of the Rivers Apurímac, Ene, and Mantaro) region. This acquisition is crucial for maintaining the operational readiness and health standards of the military personnel. Potential bidders are expected to meet specific technical and quality requirements for the supplied medicines, adhering to national and international pharmaceutical standards. Further details regarding the specific types and quantities of medicines, delivery schedules, and evaluation criteria will be provided in the tender documents. This process represents a significant procurement for the Peruvian Army's logistical and healthcare support systems.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 583,026.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.